131 related articles for article (PubMed ID: 6140786)
1. [Ranitidine (Zantac). A new H2 receptor antagonist].
Bendtsen F; Danø P
Ugeskr Laeger; 1983 Nov; 145(47):3681-2. PubMed ID: 6140786
[No Abstract] [Full Text] [Related]
2. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
Simon B; Müller P; Dammann HG
Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
[TBL] [Abstract][Full Text] [Related]
3. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
Tani N; Miwa T
Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
[No Abstract] [Full Text] [Related]
4. [Visible spectrophotometric assay of ranitidine].
Apostu M; Dorneanu V; Bibire N
Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):214-7. PubMed ID: 14756000
[TBL] [Abstract][Full Text] [Related]
5. [Medical therapy of peptic ulcer: problems and prospects].
Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
[TBL] [Abstract][Full Text] [Related]
6. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
Senfft U
Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463
[No Abstract] [Full Text] [Related]
7. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
Grigor'ev PIa; Isakov VA
Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
[No Abstract] [Full Text] [Related]
8. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
10. [Ranitidine: a new histamine H2 receptor blockader].
Duan ZB
Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):309-12. PubMed ID: 2874962
[No Abstract] [Full Text] [Related]
11. Ranitidine v. cimetidine in peptic ulcer.
Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213
[No Abstract] [Full Text] [Related]
12. New horizons in the pharmacologic management of peptic ulceration.
Debas HT; Mulholland MW
Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
[TBL] [Abstract][Full Text] [Related]
13. [Serum concentration of prolactin, gastrin and glycocholic acid in patient with peptic ulcer treated with ranitidine].
Przybyłowski J; Kowalski D; Widłak H; Kowalska K; Maślany P
Pol Tyg Lek; 1995; 50(1-35):794-6. PubMed ID: 11785198
[TBL] [Abstract][Full Text] [Related]
14. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Chan FK; Sung JJ
N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
[No Abstract] [Full Text] [Related]
15. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
16. [Effect of the histamine H2-receptor antagonist zantac on lipid peroxidation an antioxidant system in patients with gastroduodenal hemorrhage of ulcer etiology].
Ermolov AS; Pakhomova GV; Taeritneva LF; Matveev SB; Marchenko VV; Golikov PP
Patol Fiziol Eksp Ter; 1996; (1):23-5. PubMed ID: 8657447
[TBL] [Abstract][Full Text] [Related]
17. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
18. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
19. H2-receptor antagonists an Helicobacter pylori eradication.
Lamers CB
Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine and gastrointestinal bleeding in intensive care. Should prophylaxis against stress ulcer be abondoned for patients in intensive care.
Preiser JC
BMJ; 2001 Apr; 322(7292):995. PubMed ID: 11339222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
